C12N 2710/10331
Uses of virus other than therapeutic or vaccine
Official title: Uses of virus other than therapeutic or vaccine, e.g. disinfectant
C12N2710/10331 (Uses of virus other than therapeutic or vaccine) appears on 8 US grants and 14 published applications in this corpus.
Search patents in C12N- Granted patents
- 8
- Published applications
- 14
- Assignees
- 8
- Inventors
- 21
- Latest grant
- 28 Sep 2021
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2014 | 0 | 2 |
| 2015 | 0 | 1 |
| 2016 | 2 | 2 |
| 2017 | 1 | 2 |
| 2018 | 1 | 2 |
| 2019 | 2 | 1 |
| 2020 | 1 | 0 |
| 2021 | 1 | 1 |
| 2022 | 0 | 1 |
| 2023 | 0 | 0 |
| 2024 | 0 | 1 |
| 2025 | 0 | 1 |
By publication year.
Recent patents
- High throughput assay for measuring adenovirus replication kinetics28 Sep 2021US 11,130,968 B2The Salk Institute for Biological Studies
- Multitargeting onocolytic adenovirus, methods of use, and methods of making14 Apr 2020US 10,617,729 B2The UAB Research Foundation
- Method for preventing the unfolding of a (poly)peptide and/or inducing the (re-)folding of a (poly)peptide24 Sep 2019US 10,421,776 B2Leukocare AG
- Recombinant adeno-associated virus capsids with enhanced human skeletal muscle tropism20 Aug 2019US 10,385,320 B2The Board of Trustees of the Leland Stanford Junior University
- Adenoviral tumor diagnostics6 Feb 2018US 9,885,090 B2The Salk Institute for Biological Studies
- High throughput assay for measuring adenovirus replication kinetics8 May 2025US 2025/0146013 A1The Salk Institute for Biological Studies
- Method for purifying virus1 Feb 2024US 2024/0035002 A1Oxford University Innovation Limited
- High throughput assay for measuring adenovirus replication kinetics24 Mar 2022US 2022/0090123 A1The Salk Institute for Biological Studies
- Bio-imaging probes and methods for non-invasive detection of human uterine sarcomas12 Aug 2021US 2021/0244832 A1
- Novel recombinant adeno-associated virus capsids with enhanced human skeletal muscle tropism26 Dec 2019US 2019/0390176 A1The Board of Trustees of the Leland Stanford Junior University
Most cited
By later US patents
- Recombinant adeno-associated virus capsids with enhanced human skeletal muscle tropism19US 10,385,320 B2The Board of Trustees of the Leland Stanford Junior University · 2019
- Multitargeting onocolytic adenovirus, methods of use, and methods of making9US 10,617,729 B2The UAB Research Foundation · 2020
- Adenoviral tumor diagnostics9US 9,885,090 B2The Salk Institute for Biological Studies · 2018
- High throughput assay for measuring adenovirus replication kinetics3US 11,130,968 B2The Salk Institute for Biological Studies · 2021